ABEO Abeona Therapeutics Inc.
Abeona Therapeutics Inc. (ABEO) Insider Activity
What the officers, directors and large holders did with their own shares. Only open-market purchases and sales count toward the totals — grants, option exercises and shares withheld for tax are compensation mechanics, not decisions, and they're listed separately below.
How much of that selling was preplanned? 0% planned / 100% discretionary
Largest single sale: $473.3K.
Where they traded
No open-market insider purchase on record.
Recent open-market activity
| Date | Insider | Role | Action | Shares | Price | Value | Held after |
|---|---|---|---|---|---|---|---|
| Alvino Mark | Director | Sell | 15,000 | $5.86 | $88.0K | 62,065 −19.5% of holding | |
| Vazzano Joseph Walter | Chief Financial Officer | Sell | 1,478 | $6.53 | $9.7K | 492,079 −0.3% of holding | |
| Seshadri Vishwas | Chief Executive Officer | Sell | 67,971 | $6.96 | $473.3K | 1,306,108 −4.9% of holding | |
| Vazzano Joseph Walter | Chief Financial Officer | Sell | 24,880 | $6.96 | $173.3K | 493,557 −4.8% of holding | |
| Vasanthavada Madhav | Chief Commercial Officer | Sell | 12,606 | $6.96 | $87.8K | 290,623 −4.2% of holding | |
| O'Malley Brendan M. | SVP, Chief Legal Officer | Sell | 12,050 | $6.96 | $83.9K | 427,953 −2.7% of holding | |
| Alland Leila | Director | Sell | 11,000 | $5.92 | $65.1K | 162,614 −6.3% of holding |
Form 4s are due within two business days of a transaction, so this is close to real time — unlike the quarterly 13F data on the Institutional tab. A single large sale often reflects a prearranged 10b5-1 plan rather than a fresh view, so read a pattern of sales rather than any one of them.